Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
166 hedge funds and large institutions have $851M invested in Meridian Bioscience Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 56 reducing their positions, and 23 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 56
2% less funds holding
Funds holding: 170 → 166 (-4)
13% less call options, than puts
Call options by funds: $435K | Put options by funds: $498K
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
20% less capital invested
Capital invested by funds: $1.06B → $851M (-$207M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
+$19M |
| 2 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
+$7.11M |
| 3 |
Renaissance Technologies
New York
|
+$6.73M |
| 4 |
CAI
Capital Advisors Inc
Tulsa,
Oklahoma
|
+$4.43M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$21.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |
| 3 |
CFC
Cincinnati Financial Corp
Fairfield,
Ohio
|
-$12.6M |
| 4 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$5.98M |
| 5 |
CAM
Capstone Asset Management
Houston,
Texas
|
-$3.46M |
VIVO Hedge Fund Activity: Q1 2014 in Review
166 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2014, worth a combined $851M — down 20% from $1.06B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of VIVO and 19 opened new positions — a net loss of 4 holders — while 56 trimmed existing stakes and 61 added.
The largest buyer was Perkins Investment Management, opening a new position worth an estimated $19M. The largest seller was Invesco, cutting an estimated $21.5M.
- 166 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2014, down from 170 in Q4 2013.
- Funds reported $851M of Meridian Bioscience Inc stock for Q1 2014, down 20% quarter-over-quarter.
- 19 funds opened new Meridian Bioscience Inc positions in Q1 2014 and 23 closed out, a net change of -4 holders.
- The largest Meridian Bioscience Inc buyer in Q1 2014 was Perkins Investment Management, an estimated $19M added.
- The largest Meridian Bioscience Inc seller in Q1 2014 was Invesco, an estimated $21.5M sold.
Based on aggregated 13F filings for Q1 2014.